Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial

about

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial Adjuvant Endocrine Therapy and Bone Health in Breast Cancer.

P2860

Q36616992-0D83A79C-41F4-43DA-8448-A0F5CC1A3080 Q38553766-233EE500-348B-4F37-BA5C-142A3FFDDF3F

P2860

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial

Item

http://www.wikidata.org/entity/Q36162366

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Age effect on bone mineral den ...... RBI prospective clinical trial

@ast

Age effect on bone mineral den ...... RBI prospective clinical trial

@en

type

Item

label

Age effect on bone mineral den ...... RBI prospective clinical trial

@ast

Age effect on bone mineral den ...... RBI prospective clinical trial

@en

prefLabel

Age effect on bone mineral den ...... RBI prospective clinical trial

@ast

Age effect on bone mineral den ...... RBI prospective clinical trial

@en

P1476

Age effect on bone mineral den ...... RBI prospective clinical trial

@en

P2093

Basileios Venizelos

http://www.w3.org/2001/XMLSchema#string

Christos Markopoulos

http://www.w3.org/2001/XMLSchema#string

Dimitrios Koukouras

http://www.w3.org/2001/XMLSchema#string

Evagelos Tzoracoleftherakis

http://www.w3.org/2001/XMLSchema#string

Grigorios Xepapadakis

http://www.w3.org/2001/XMLSchema#string

Helen Gogas

http://www.w3.org/2001/XMLSchema#string

John Misitzis

http://www.w3.org/2001/XMLSchema#string

Vasilios Zobolas

http://www.w3.org/2001/XMLSchema#string

P2860

Development of bisphosphonates.

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Toxicity and response criteria of the Eastern Cooperative Oncology Group

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.

Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.

Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative.

Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

P2888

s00432-012-1233-z

P304

1569-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-012-1233-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224888476

http://www.w3.org/2001/XMLSchema#string

P698

22552718

http://www.w3.org/2001/XMLSchema#string

P932

3418493

http://www.w3.org/2001/XMLSchema#string

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial

about

P2860

P2860

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932